Affiliation:
1. Interfaculty Institute of Biochemistry (IFIB) University of Tübingen Auf der Morgenstelle 34 72076 Tübingen Germany
2. Institut für pharmazeutische Biologie and Biotechnologie Fachbereich Pharmazie Philipps-Universität Marburg Robert-Koch-Straße 4 35037 Marburg Germany
Abstract
AbstractCyclodipeptides (CDPs) build an important class of secondary metabolites with a plethora of pharmacological impact such as antibiotic, cytotoxic, antifungal properties or even as anti‐Alzheimer drug candidates. The core structure of 2,5‐diketopiperazines, a subclass of CDPs, is composed of two ‘head‐to‐tail’ connected α‐amino acids. Their chemical diversity is broadened by tailoring enzymes as members of their biosynthetic gene clusters, such as CDP‐dimerizing P450s. Recently, a new class of P450 enzymes, termed GymBx, was identified in the biosynthetic pathway of guatyromycines. These enzymes catalyse both an intramolecular C−C bond formation within cyclo‐l‐Tyr‐l‐Tyr (cYY) and a nucleobase transfer reaction, which is unique for CDP‐modifying P450 enzymes. In this study, we report the structures of two members, GymB1 and GymB5, in their unbound states, as well as GymB5 in complex with hypoxanthine and cYY. Structural data of the ternary complex shed light into CDP binding and nucleobase transfer reaction, identified key residues for substrate recognition and modified the enzymatic bifunctionality. By mutagenesis we successfully established a GymB5 variant that strictly switched the chemoselectivity of the reaction towards an intermolecular coupling enzyme. This data set a solid basis for future protein engineering of P450 enzymes to synthesize new CDP‐nucleobase adducts.
Funder
Deutsche Forschungsgemeinschaft